article thumbnail

A long and ongoing look at the secrets of human longevity and healthy aging

Science Daily: Pharmacology News

Researchers participating in the Cilento Initiative on Aging Outcomes or CIAO study will gather in Acciaroli (Pollica-Cilento) Salerno, Italy to review a decade of work and plan their next steps.

article thumbnail

Broad Institute and Manifold collaborate to build AI-enabled life sciences research platform to accelerate global discoveries

Broad Institute

By TK January 13, 2025 The Broad Institute of MIT and Harvard today announced a strategic collaboration with Manifold , a leader in research infrastructure for biomedical science, to develop a cutting-edge research platform. Founded in 2016, Manifold is an AI-powered platform accelerating biomedical research.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

David Liu receives Breakthrough Prize in Life Sciences

Broad Institute

Base editing, which Lius team developed in 2016, is a gene editing technique that directly converts an individual DNA base pair into a different base pair. During his doctoral research at University of California Berkeley, Liu initiated the first general effort to expand the genetic code in living cells.

article thumbnail

Boosters and Biologics: Is Space-Based Biomanufacturing Real?

LifeSciVC

Merck, Bristol-Myers Squibb, Amgen, Eli Lilly, and Gilead have all conducted microgravity research in orbit. With respect to the latter, Mercks microgravity research on Keytruda is an informative case study. Despite the progress made, microgravity research projects to date have been exploratory, small-scale one-offs.

article thumbnail

"Designer Drugs" in the 21st Century

Common Sense for Drug Policy Blog

The term is currently applied more widely to include substances that originate from industrial or academic research but never receive medical approval. 2016 ; Zawilska and Wojcieszak 2019 ). 2019 ; Manchester et al. 2018 ; Owen et al.

article thumbnail

The rising impact of biomarkers in early clinical development

Drug Target Review

Silver Spring (MD): Food and Drug Administration (US); 2016-. About the author Dr Cyril Clarke, Vice President, Therapeutic Area, GMI Drug Development and Consulting, ICON Biotech Clarke is a clinical pharmacologist with over 30 years experience in clinical research; seventeen of which are within industrial clinical pharmacology.

article thumbnail

Q&A: One scientist’s bold vision to make on-demand treatments routine for life-threatening rare genetic diseases

Broad Institute

Related groups Liu Group Related news New CRISPR genome editing system offers a wide range of versatility in human cells Researchers extend power of gene editing by developing a new class of DNA base editors In May 2025, researchers announced that K.J. The team that treated K.J. Some of these treatments, like K.J.’s,